Radical prostatectomy as radical cure of prostate cancer in a high‑risk group: A single-institution experience

Furubayashi,Nobuki; Nakamura,Motonobu; Hishikawa,Ken; Fukuda,Atsushi; Matsumoto,Takashi; Nishiyama,Kenichi; Yamanaka,Takeharu; Hasegawa,Yoshihiro

doi:10.3892/mco.2012.39

March-April 2013 Volume 1 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-April 2013 Volume 1 Issue 2

Full Size Image

Article

Radical prostatectomy as radical cure of prostate cancer in a high‑risk group: A single-institution experience

Authors:
- Nobuki Furubayashi
- Motonobu Nakamura
- Ken Hishikawa
- Atsushi Fukuda
- Takashi Matsumoto
- Kenichi Nishiyama
- Takeharu Yamanaka
- Yoshihiro Hasegawa
View Affiliations / Copyright

Affiliations: Department of Urology, National Kyushu Cancer Center, Fukuoka, Japan, Department of Pathology, National Kyushu Cancer Center, Fukuoka, Japan, Institute for Clinical Research, National Kyushu Cancer Center, Fukuoka, Japan
Pages: 337-342
|
Published online on: November 15, 2012

https://doi.org/10.3892/mco.2012.39
Expand metrics +

Abstract

This study aimed to evaluate the possibility of performing radical prostatectomy (RP) alone to achieve radical cure of prostate cancer in a high‑risk group. Between August 1998 and December 2008, 436 Japanese patients underwent antegrade RP following the exclusion of 139 patients. According to the D'Amico criteria, the low-, intermediate- and high‑risk groups comprised 63, 122 and 112 patients, respectively. Twenty-five patients who were classified into the high‑risk group based only on T2c stage, were evaluated as a separate intermediate/high‑risk group. Results of the multivariate analysis revealed that of the preoperative characteristics only a biopsy Gleason score was a significant predictor in patients with and without PSA failure (P=0.017). After a median follow‑up period of 60 months, the PSA failure‑free rates in the low-, intermediate-, high‑ and intermediate/high‑risk groups were 96.5, 92.2, 76.8 and 95.0%, respectively. No statistically significant difference was detected in the high‑ and intermediate/high‑risk groups (P=0.064). Thus, patients classified into the high‑risk group based on cT2 stage only, are considered to be potentially eligible for radical treatment by surgery alone, and should not be evaluated as high‑risk patients.

View Figures

View References

1	D’Amico AV, Whittington R, Malkowicz SB, et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 280:969–974. 1998.
2	Epstein JI, Allsbrook WC Jr, Amin MB and Eqevad LL; ISUP Grading Committee: The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of prostatic carcinoma. Am J Surg Pathol. 29:1228–1242. 2005. View Article : Google Scholar : PubMed/NCBI
3	Sobin LH, Gospodarowicz MK and Wittekind Ch: TNM Classification of Malignant Tumors. 7th edition. Wiley-Blackwell; Oxford: 2009
4	Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS and Carroll PR: Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology. 59:560–565. 2002. View Article : Google Scholar
5	D’Amico AV, Whittington R, Malkowicz SB, et al: Predicting prostate specific antigen outcome preoperatively in the prostate specific antigen era. J Urol. 166:2185–2188. 2001.PubMed/NCBI
6	Manoharan M, Bird VG, Kim SS, Civantos F and Soloway MS: Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8. BJU Int. 92:539–544. 2003.
7	Boorjian SA, Kames RJ, Crispen PL, Ragel LJ, Berqstralh EJ, Sebo TJ and Blute ML: The impact of discordance between biopsy and pathological Gleason scores on survival after radical prostatectomy. J Urol. 181:95–104. 2009. View Article : Google Scholar : PubMed/NCBI
8	Kawamorita N, Saito S, Ishidoya S, Ito A, Saito H, Kato M and Arai Y: Radical prostatectomy for high-risk prostate cancer: biochemical outcome. Int J Urol. 16:733–738. 2009. View Article : Google Scholar : PubMed/NCBI
9	Mian BM, Troncoso P, Okihara K, Bhadkamkar V, Johnston D, Reves AO and Babaian RJ: Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol. 167:1675–1680. 2002. View Article : Google Scholar : PubMed/NCBI
10	Byar DP and Mostofi FK: Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer. 30:5–13. 1972. View Article : Google Scholar
11	Cooperberg MR, Cowan J, Broering JM and Carroll PR: High-risk prostate cancer in the United States, 1990–2007. World J Urol. 26:211–218. 2008.

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Radical prostatectomy as radical cure of prostate cancer in a high‑risk group: A single-institution experience

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Related Articles